166 related articles for article (PubMed ID: 30724464)
41. Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent.
Recks MS; Addicks K; Kuerten S
Neurosci Lett; 2011 May; 494(3):227-31. PubMed ID: 21406210
[TBL] [Abstract][Full Text] [Related]
42. Quantitative analysis of spinal cord neuropathology in experimental autoimmune encephalomyelitis.
Wuerch E; Mishra M; Melo H; Ebacher V; Yong VW
J Neuroimmunol; 2022 Jan; 362():577777. PubMed ID: 34823122
[TBL] [Abstract][Full Text] [Related]
43. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D
Haghmorad D; Yazdanpanah E; Jadid Tavaf M; Zargarani S; Soltanmohammadi A; Mahmoudi MB; Mahmoudi M
Neurol Res; 2019 Oct; 41(10):943-957. PubMed ID: 31402771
[TBL] [Abstract][Full Text] [Related]
44. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
45. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
46. Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
Nathoo N; Agrawal S; Wu Y; Haylock-Jacobs S; Yong VW; Foniok T; Barnes S; Obenaus A; Dunn JF
Mult Scler; 2013 May; 19(6):721-31. PubMed ID: 23027879
[TBL] [Abstract][Full Text] [Related]
47. Cell Fusion along the Anterior-Posterior Neuroaxis in Mice with Experimental Autoimmune Encephalomyelitis.
Sankavaram SR; Svensson MA; Olsson T; Brundin L; Johansson CB
PLoS One; 2015; 10(7):e0133903. PubMed ID: 26207625
[TBL] [Abstract][Full Text] [Related]
48. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
[TBL] [Abstract][Full Text] [Related]
49. The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS).
Braitch M; Constantinescu CS
Inflamm Allergy Drug Targets; 2010 Sep; 9(4):249-56. PubMed ID: 20887272
[TBL] [Abstract][Full Text] [Related]
50. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
51. Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
Herrmann MM; Barth S; Greve B; Schumann KM; Bartels A; Weissert R
Dis Model Mech; 2016 Oct; 9(10):1211-1220. PubMed ID: 27519689
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Martin J; Pozo D; Ganea D; Delgado M
Am J Pathol; 2006 Apr; 168(4):1179-88. PubMed ID: 16565493
[TBL] [Abstract][Full Text] [Related]
53. Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.
Liu T; Donahue KC; Hu J; Kurnellas MP; Grant JE; Li H; Elkabes S
J Proteome Res; 2007 Jul; 6(7):2565-75. PubMed ID: 17571869
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-92a Drives Th1 Responses in the Experimental Autoimmune Encephalomyelitis.
Rezaei N; Talebi F; Ghorbani S; Rezaei A; Esmaeili A; Noorbakhsh F; Hakemi MG
Inflammation; 2019 Feb; 42(1):235-245. PubMed ID: 30411211
[TBL] [Abstract][Full Text] [Related]
55. Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis.
Rosenling T; Stoop MP; Attali A; van Aken H; Suidgeest E; Christin C; Stingl C; Suits F; Horvatovich P; Hintzen RQ; Tuinstra T; Bischoff R; Luider TM
J Proteome Res; 2012 Apr; 11(4):2048-60. PubMed ID: 22320401
[TBL] [Abstract][Full Text] [Related]
56. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice.
Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X
Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389
[TBL] [Abstract][Full Text] [Related]
58. The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis.
Kamizato K; Sato S; Shil SK; Umaru BA; Kagawa Y; Yamamoto Y; Ogata M; Yasumoto Y; Okuyama Y; Ishii N; Owada Y; Miyazaki H
Neuroscience; 2019 Jun; 409():120-129. PubMed ID: 31051217
[TBL] [Abstract][Full Text] [Related]
59. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
[TBL] [Abstract][Full Text] [Related]
60. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.
Kuerten S; Angelov DN
Ann Anat; 2008; 190(1):1-15. PubMed ID: 18342137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
